Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

Topics in Gastrointestinal Cancer 2019

DFBWMGH_1.10.14_updated version.jpg

Thank you for your interest in this CME program. Online registration has now closed. If you're still interested in attending, we will be accepting on-site registrations on Saturday morning, February 2nd, beginning at 7:45 am. PLEASE NOTE: Cash and credit cards are NOT accepted on-site. Checks only for the registration payment.

Saturday, February 2, 2019

7:45 a.m. - 2:00 p.m.

Four Seasons Hotel
200 Boylston Street
Boston, MA 02116

Course Description

Novel treatment options for gastrointestinal cancers and the introduction of biomarkers have resulted in considerable improvements in patient outcomes but have also increased the complexity of treatment decisions for practicing clinicians. This annual CME symposium led by Dana-Farber/Brigham and Women's Cancer Center and Massachusetts General Hospital Cancer Center will provide attendees with the latest information on managing and treating gastrointestinal cancers, including colorectal, pancreatic, and gastroesophageal cancers, hepatocellular carcinoma, neuroendocrine tumors, and hereditary GI cancer syndromes. Through lecture, panel discussion, and Q&A, this course is designed to help practitioners integrate this knowledge into their own daily practice.

Learning Objectives

Upon completion of this course, attendees will be able to:

1. Evaluate new surgical approaches for pancreatic tumors and cystic lesions and apply these procedures into routine clinical practice.
2. Recognize new management and treatment options for colon, rectum, and neuroendocrine tumors.
3. Identify management programs for localized gastroesophageal cancer involving chemotherapy, radiation, immunotherapy, and surgery.
4. Evaluate the role of inherited genetics and when & why practitioners should do germline genetic testing.
5.Recognize the different and emerging types of radiation therapy in gastrointestinal cancers, specifically stereotactic body radiation therapy (SBRT), MRI-guided therapy, and radiosensitizers.
6. Consider therapy options for patients with liver cancer, including liver-directed therapy, targeted therapies, and immunotherapy

Target Audience

This educational activity is designed for: medical and radiation oncologists, colon and rectal surgeons, gastroenterologists, primary care physicians, nurse practitioners, nurses, and other interested clinicians involved in the care of patients with GI cancers.


7:45 a.m.

Registration Check-in and Continental Breakfast


Welcome and Introduction
Brian M. Wolpin, MD, MPH


Multidisciplinary Management of Hepatocellular Carcinoma: Making Sense of the Wealth of New Therapy Options
Andrew X. Zhu, MD, PhD


Hereditary Cancer Syndromes: Evaluation and Management
Matthew B. Yurgelun, MD


Management Controversies in Colorectal Cancer
Jeffrey A. Meyerhardt, MD, MPH


Therapy Approaches for Neuroendocrine Tumors: Local, Systemic, and Radioactive
Jennifer Chan, MD, MPH




Surgical Approaches to Pancreatic Tumors and Cystic Lesions
Carlos Fernandez-del Castillo, MD


Emerging Approaches to Radiation for GI Malignancies, including SBRT, MRI-guided Therapy, and Radiosensitizers
Joseph D. Mancias, MD, PhD


How I Treat Localized Gastroesophageal Cancer: Chemo and Beamo
Theodore S. Hong, MD and Peter C. Enzinger, MD

12:15 p.m.

Case Presentations from the Audience*
Moderator: Brian M. Wolpin, MD, MPH
Panelists:Jeffrey A. Meyerhardt, MD, MPH
Joseph D. Mancias, MD
Carlos Fernandez-del Castillo, MD
Andrew X. Zhu, MD, MD
Theodore S. Hong, MD
Peter C. Enzinger, MD
Matthew B. Yurgelun, MD
Jennifer Chan, MD

*Participants will be encouraged to present their own problem cases for discussion by the panel, and are encouraged to bring case materials, including scans and other diagnostic information.


Concluding Remarks
Brian M. Wolpin, MD, MPH



2:00 p.m.

Meeting Adjourns

Please note: Program changes/substitutions may be made without notice.


Brian M. Wolpin, MD, MPH -Course Director & Program Moderator
Director, Gastrointestinal Cancer Center,
Robert T. and Judith B. Hale Chair in Pancreatic Cancer,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Carlos Fernandez-del Castillo, MD
Clinical Co-Director, Gastrointestinal Cancer Center,
Director, Pancreas and Biliary Surgery Program,
Massachusetts General Hospital Cancer Center;
Professor of Surgery, Harvard Medical School

Jennifer Chan, MD, MPH
Director, Program in Carcinoid and Neuroendocrine Tumors,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Peter C. Enzinger, MD
Director, Center for Esophageal and Gastric Cancer,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Theodore S. Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology,
Associate Clinical Director, Department of Radiation Oncology,
Massachusetts General Hospital Cancer Center;
Associate Professor of Radiation Oncology, Harvard Medical School

Joseph D. Mancias, MD, PhD
Radiation Oncologist, Gastrointestinal Cancer Center,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Radiation Oncology, Harvard Medical School

Jeffrey A. Meyerhardt, MD, MPH
Clinical Director, Gastrointestinal Cancer Center,
Douglas Gray Woodruff Chair in Colorectal Cancer Research,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School

Matthew B. Yurgelun, MD
Medical Oncologist, Gastrointestinal Cancer Center and
Center for Cancer Genetics and Prevention,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Andrew X. Zhu, MD, PhD
Director, Liver Cancer Research,
Massachusetts General Hospital Cancer Center;
Professor of Medicine, Harvard Medical School

Registration Information

Registration Fee
- $75.00 through January 20, 2019
- $85.00 after January 20, 2019
(Registration fee is non-refundable and includes course materials, continental breakfast, and lunch).

Forms of payment accepted:
- Online: Credit card
- Mail/On-site: Check only
(Please note, cash is not accepted)

Course Location and Directions

This course will be held at the Four Seasons Hotel, 200 Boylston Street, Boston MA 02116.

For directions, click here (URL link:


For questions regarding registration, please contact the Partners Office of Continuing Professional Development at or 857-282-2515.

For questions regarding the conference, please call 800-553-3787.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator 10 days prior to the event at; 800-553-3787.

Additional Information

About the Gastrointestinal Cancer Centers of Dana-Farber/Brigham and Women's Cancer Center and Massachusetts General Hospital Cancer Center

We offer comprehensive care for patients with gastrointestinal cancers, including cancers of the colon, rectum, stomach, esophagus, pancreas, anus, bile duct (cholangiocarcinoma), liver, gallbladder, and small bowel, as well as carcinoid and islet cell malignancies. At each cancer center, care is provided by a multidisciplinary team that includes medical oncologists; radiation oncologists; colorectal, gastrointestinal, and oncologic surgeons; and gastroenterologists, with consultative support from gastrointestinal pathologists and gastrointestinal diagnostic and interventional radiologists.

These Harvard Medical School-affiliated centers provide the latest therapies in surgery, chemotherapy, and radiation for gastrointestinal cancers. Both centers also have active clinical research programs exploring new drug treatments and multimodality therapies. Genetic counseling, molecular diagnostic testing, and support services, including social work, nutrition counseling, and educational and support groups are also offered.

Provided by

Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center, & Partners HealthCare System

DFBWMGH_1.10.14_updated version.jpg


CME Information


Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of4.25 AMA PRA Category 1 CreditsTM.Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Dana-Farber Cancer Institute is an approved provider of continuing nursing education by the American Nurses Association Massachusetts, an accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation.

4.25 nursing contact hours will be awarded for attending the event in its entirety and completion of an evaluation.

Privacy Statement

This website uses Echo360 technologies. Echo360 partners with the world’s leading educational institutions and industry associations to enhance the teaching and learning experience for students and professionals like you. Our goal is to enable a more engaging and successful learning experience by providing you with live and on-demand access to study tools, videos, and collaboration capabilities in an online classroom to help you achieve your educational goals. We believe you should always know what data we collect from you and how we use it. As part of our ongoing commitment to transparency, and to support new European data protection laws, we're updating our Privacy Policy to inform you about the information that you share with us. The revised policy will take effect on May 25, 2018. By using our services on or after that date, you'll be agreeing to these updates. We encourage you to read this document in full. Echo360, Inc. 11955 Freedom Drive, Suite 700, Reston, VA 20190 USA